Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.43% Nasdaq Down0.35%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS

7.88 Mar 18, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Sep 29, 2012Jun 29, 2012Mar 30, 2012
Total Revenue 1,936   1,485   21,977   2,189  
Cost of Revenue832  1,396  652  791  
Gross Profit 1,104   89   21,325   1,398  
Operating Expenses
Research Development13,947  11,619  14,076  14,470  
Selling General and Administrative7,263  7,392  5,216  6,355  
Non Recurring -   -   -   -  
Others174  168  173  176  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (20,280) (19,090) 1,860   (19,603)
Income from Continuing Operations
Total Other Income/Expenses Net796  5,373  (21,470)(3,943)
Earnings Before Interest And Taxes(19,484)(13,717)(19,610)(23,546)
Interest Expense1,796  1,804  2,489  3,031  
Income Before Tax(21,280)(15,521)(22,099)(26,577)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(21,280)(15,521)(26,767)(28,247)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (21,280) (15,521) (22,099) (26,577)
Preferred Stock And Other Adjustments -   -   -  (2,824)
Net Income Applicable To Common Shares (21,280) (15,521) (22,099) (29,401)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.